2017
DOI: 10.1186/s12872-017-0616-0
|View full text |Cite
|
Sign up to set email alerts
|

Takotsubo cardiomyopathy complicated with apical thrombus formation on first day of the illness: a case report and literature review

Abstract: BackgroundTakotsubo cardiomyopathy is characterized by transient systolic dysfunction of the apical and mid segments of the left ventricle in the absence of obstructive coronary artery disease. Intraventricular thrombus formation is a rare complication of Takotsubo cardiomyopathy and current data almost exclusively consists of isolated case reports and a few case series. Here we describe a case of Takotsubo cardiomyopathy with formation of an apical thrombus within 24 h of symptom onset, which has been reporte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
25
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(26 citation statements)
references
References 52 publications
0
25
0
1
Order By: Relevance
“…This case series and the published cases listed in Table 2 demonstrate that therapeutic anticoagulation in TTS-related LV thrombi may not completely protect from embolic events in every case. It has been recommended that patients with TTS-related ventricular thrombi should be treated with anticoagulant therapy for 3 months, since usually the wall motion abnormality resolves within this period of time [7, 10, 11]. This recommendation derives from data on LV thrombi associated with acute myocardial infarction, most frequently anterior ST elevation myocardial infarction (STEMI) [16, 17].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…This case series and the published cases listed in Table 2 demonstrate that therapeutic anticoagulation in TTS-related LV thrombi may not completely protect from embolic events in every case. It has been recommended that patients with TTS-related ventricular thrombi should be treated with anticoagulant therapy for 3 months, since usually the wall motion abnormality resolves within this period of time [7, 10, 11]. This recommendation derives from data on LV thrombi associated with acute myocardial infarction, most frequently anterior ST elevation myocardial infarction (STEMI) [16, 17].…”
Section: Discussionmentioning
confidence: 99%
“…Possible mechanisms for thrombus formation in TTS are transient LV regional wall motion abnormalities resulting in the local activation of hemostasis, endocardial injury with regional exposure or release of thrombogenic substances and influence of catecholamines on nucleotide-induced platelet aggregation [10]. In the literature, most of the thrombi have been described in patients with apical TTS; however, in contrast to the assumption of Santoro et al [7, 9], midventricular TTS may equally be associated with thrombus formation, as seen in one of our patients [4, 6, 18, 19].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In a previous report, anticoagulation therapy mainly with heparin or warfarin was used for LV thrombus. 4) If a thrombus appears with LV aneurysm after myocardial infarction, surgical thrombectomy with LV-plasty might be considered. There are only a few TC cases that underwent LV-plasty or thrombectomy in previous reports.…”
Section: Discussionmentioning
confidence: 99%
“…The rare incidence of left ventricular thrombus has been reported in other diseases, including takotsubo cardiomyopathy [2], heparin-induced thrombocytopenia [3], Behçet disease [4], and disseminated intravascular coagulation [5]. There are limited data as to the exact frequency of LV thrombus in patients with ischemic stroke, but it has been reported to be about 2.4% in symptomatic patients by transesophageal echocardiography [6].…”
Section: Discussionmentioning
confidence: 99%